Option appraisal of population-based colorectal cancer screening programmes in England.
about
Colorectal cancer screening: why immunochemical fecal occult blood tests may be the best optionA comparative case study of bowel cancer screening in the UK and Australia: evidence lost in translation?The cost of anal cancer in England: retrospective hospital data analysis and Markov model.Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.Uptake of population-based flexible sigmoidoscopy screening for colorectal cancer: a nurse-led feasibility study.Use of CT colonography in the English Bowel Cancer Screening Programme.Cost-effectiveness of colorectal cancer screening - an overview.Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.Distributional Cost-Effectiveness Analysis: A Tutorial.Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland.Sensitivity and specificity of CT colonography for the detection of colonic neoplasia after positive faecal occult blood testing: systematic review and meta-analysis.Cost-effectiveness of colorectal cancer screeningCancer care coordinators in stage III colon cancer: a cost-utility analysisCost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.Socioeconomic Disparities in Colorectal Cancer Screening in Korea: A Nationwide Cross-Sectional Study.Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.Use of hospital resources in the Finnish colorectal cancer screening programme: a randomised health services study.The UK colorectal cancer screening pilot: results of the second round of screening in England.Review of economic evidence in the prevention and early detection of colorectal cancer.Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.Systematic review of economic evidence for the detection, diagnosis, treatment, and follow-up of colorectal cancer in the United Kingdom.Cost of care for colorectal cancer in Ireland: a health care payer perspective.Screening for colorectal cancer: established and emerging modalities.Screening for colorectal cancer: what fits best?Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test.Colorectal cancer screening--optimizing current strategies and new directions.The National Health Service Bowel Cancer Screening Program: the early years.Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer.Cost-effectiveness analysis of 3-D computerized tomography colonography versus optical colonoscopy for imaging symptomatic gastroenterology patients.Modeling and validating the cost and clinical pathway of colorectal cancer.Impact of the bowel-screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran.Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening.Predicting the impact of the screening programme for colorectal cancer in the UK.Colorectal Cancer Screening-Who, How, and When?Reappraisal of the options for colorectal cancer screening in England.Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.Bayesian calibration of a natural history model with application to a population model for colorectal cancer.The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study."SPECC and SPECULATION": Is a significant polyp benign or an early colorectal cancer? How do we know and what do we do?
P2860
Q26997310-C255ECE2-7EB3-44D6-87CD-01B4F8FD8DEFQ27022198-01A95D4F-1A9A-4AC8-9CFA-7DF33ABF2AE5Q30866180-97CD8D97-C8B8-448B-89E3-3D83B4BE0C1BQ31032948-041674DC-9F95-4EB5-A3C9-1ECF2E395967Q33633657-40FF6F2E-D990-4DCF-A201-4DDD10736C64Q33659952-A47483A0-417C-4A27-BA2A-1032A2A1DD70Q34125840-DE517221-3E1E-4692-9DF4-593DD7E3757CQ34418928-8C296359-DCF7-4BB9-B750-49DE673181EDQ34473483-11B5B4B5-8175-4DFC-8363-8AD6880AE83CQ34627515-32A2E14D-1606-4C68-BDAE-3380F4D4CFFDQ35092375-63609325-5596-4930-A7B3-C445BF689314Q35095108-A40AE581-EFA5-4BEE-AE30-8BCF7FD774E9Q35736059-AFB78755-5117-4EAF-A71E-C9BFC9A251EAQ35809264-76956310-A8AE-422C-8C65-1F1BA54C2428Q35835091-0CAB1B08-DE2D-42D7-B3BF-789A6663E4C6Q36195917-298C93A4-4E67-4928-923A-0A567D431942Q36221516-E29F0725-9FCE-44FC-8B10-0E1D234B5F2DQ36405811-9F411C54-E5DF-4D4F-B3BC-657F9B593490Q36610741-2B633B5C-5352-4883-937B-14BAEAFCDF2AQ37356637-9CEB3796-6F21-46D1-9730-913E1DD8A2AAQ37395173-7081E844-EA9C-4E3F-83CC-C45A774A72B0Q37618995-B90EB393-BE09-4F1B-886D-E6E795D4AA7CQ37884446-8B0E4725-1E49-4B34-83BB-8230EBF088D3Q37951776-29B8A16D-6E70-49EA-ACAC-138049960279Q38014494-6B583D9A-B9BD-4DE0-A6EA-A44E00D5838FQ38049349-6D2F0E1C-7A88-4F5A-811E-31EF1248C7E4Q38079126-9BC20CBE-E537-43C9-AFC4-3FE8E3389271Q38125254-259810E1-CD31-4E8C-AC22-69406381492AQ38754674-B9EA300E-8480-4D8B-B10E-AFB7C772BB25Q39027269-AF564F1D-D584-4FD7-A52D-DF8DFAB2EF9FQ39151866-C51CA4F5-554D-454C-BAA0-2797A2B31429Q41975569-5EC07771-FAD3-4C0D-95A1-BAAEC48C7CD8Q44160333-C8C6F9CC-486B-4AF7-81F3-D4E335BB689FQ45787732-0E088B09-9AFA-4E35-A3C6-21E7C2443FBFQ48507159-1069BDB8-C69E-42E3-AEA4-8D081FDD7617Q50142101-9F1BEE9C-FC72-4DCB-B9CB-381AD73AD953Q51473640-9552A123-B3F6-4A9D-9E23-20191A269BE3Q51628329-49A0307B-52C0-4BE2-BE89-134002ED2B58Q51765491-BD456395-7C9C-4162-A2FD-ED88F3FB1F8FQ53104941-3EC1E3A6-BFA0-4A45-A56D-684EE7756622
P2860
Option appraisal of population-based colorectal cancer screening programmes in England.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Option appraisal of population-based colorectal cancer screening programmes in England.
@ast
Option appraisal of population-based colorectal cancer screening programmes in England.
@en
type
label
Option appraisal of population-based colorectal cancer screening programmes in England.
@ast
Option appraisal of population-based colorectal cancer screening programmes in England.
@en
prefLabel
Option appraisal of population-based colorectal cancer screening programmes in England.
@ast
Option appraisal of population-based colorectal cancer screening programmes in England.
@en
P2093
P2860
P356
P1433
P1476
Option appraisal of population-based colorectal cancer screening programmes in England.
@en
P2093
Hannah Sakai
James Chilcott
Jonathon Karnon
Paul Tappenden
Simon Eggington
P2860
P304
P356
10.1136/GUT.2006.095109
P407
P577
2006-12-01T00:00:00Z